129 related articles for article (PubMed ID: 17924141)
1. Immunohistochemical expression of estrogen receptors alpha and beta in lobular neoplasia.
Nonni A; Zagouri F; Sergentanis TN; Lazaris AC; Patsouris ES; Zografos GC
Virchows Arch; 2007 Nov; 451(5):893-7. PubMed ID: 17924141
[TBL] [Abstract][Full Text] [Related]
2. Heat shock protein90 in lobular neoplasia of the breast.
Zagouri F; Nonni A; Sergentanis TN; Papadimitriou CA; Michalopoulos NV; Lazaris AC; Patsouris E; Zografos GC
BMC Cancer; 2008 Oct; 8():312. PubMed ID: 18957107
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor-associated expression of keratinocyte growth factor and its possible role in the inhibition of apoptosis in human breast cancer.
Tamaru N; Hishikawa Y; Ejima K; Nagasue N; Inoue S; Muramatsu M; Hayashi T; Koji T
Lab Invest; 2004 Nov; 84(11):1460-71. PubMed ID: 15311216
[TBL] [Abstract][Full Text] [Related]
4. Decreased Hsp90 expression in infiltrative lobular carcinoma: an immunohistochemical study.
Zagouri F; Sergentanis T; Nonni A; Papadimitriou C; Pazaiti A; Michalopoulos NV; Safioleas P; Lazaris A; Theodoropoulos G; Patsouris E; Zografos G
BMC Cancer; 2010 Aug; 10():409. PubMed ID: 20691061
[TBL] [Abstract][Full Text] [Related]
5. Declining estrogen receptor-beta expression defines malignant progression of human breast neoplasia.
Shaaban AM; O'Neill PA; Davies MP; Sibson R; West CR; Smith PH; Foster CS
Am J Surg Pathol; 2003 Dec; 27(12):1502-12. PubMed ID: 14657709
[TBL] [Abstract][Full Text] [Related]
6. The expression of ERalpha, ERbeta and PR in lobular carcinoma in situ of the breast determined using laser microdissection and real-time PCR.
Green AR; Young P; Krivinskas S; Rakha EA; Claire Paish E; Powe DG; Ellis IO
Histopathology; 2009 Mar; 54(4):419-27. PubMed ID: 19309393
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR.
Radhi JM
Histopathology; 2000 Feb; 36(2):156-60. PubMed ID: 10672061
[TBL] [Abstract][Full Text] [Related]
8. Expression of ERalpha and ERbeta in lobular carcinoma in situ.
Middleton LP; Perkins GH; Tucker SL; Sahin AA; Singletary SE
Histopathology; 2007 Jun; 50(7):875-80. PubMed ID: 17543077
[TBL] [Abstract][Full Text] [Related]
9. Expression of estrogen receptor alpha and beta in breast cancers of pre- and post-menopausal women.
Murillo-Ortiz B; Pérez-Luque E; Malacara JM; Daza-Benítez L; Hernández-González M; Benítez-Bribiesca L
Pathol Oncol Res; 2008 Dec; 14(4):435-42. PubMed ID: 18752050
[TBL] [Abstract][Full Text] [Related]
10. DAX-1 expression in human breast cancer: comparison with estrogen receptors ER-alpha, ER-beta and androgen receptor status.
Conde I; Alfaro JM; Fraile B; Ruíz A; Paniagua R; Arenas MI
Breast Cancer Res; 2004; 6(3):R140-8. PubMed ID: 15084237
[TBL] [Abstract][Full Text] [Related]
11. The effect of prolonged fixation on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast cancer: a prospective study.
Tong LC; Nelson N; Tsourigiannis J; Mulligan AM
Am J Surg Pathol; 2011 Apr; 35(4):545-52. PubMed ID: 21358301
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1.
Neubauer H; Clare SE; Wozny W; Schwall GP; Poznanovic S; Stegmann W; Vogel U; Sotlar K; Wallwiener D; Kurek R; Fehm T; Cahill MA
Breast Cancer Res; 2008; 10(5):R85. PubMed ID: 18922159
[TBL] [Abstract][Full Text] [Related]
13. Expression of oestrogen receptor-beta in apocrine carcinomas of the breast.
Honma N; Takubo K; Akiyama F; Kasumi F; Sawabe M; Arai T; Hosoi T; Yoshimura N; Harada N; Younes M; Sakamoto G
Histopathology; 2007 Mar; 50(4):425-33. PubMed ID: 17448017
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer.
Esslimani-Sahla M; Simony-Lafontaine J; Kramar A; Lavaill R; Mollevi C; Warner M; Gustafsson JA; Rochefort H
Clin Cancer Res; 2004 Sep; 10(17):5769-76. PubMed ID: 15355905
[TBL] [Abstract][Full Text] [Related]
15. Lobular neoplasia of the breast: an update.
Contreras A; Sattar H
Arch Pathol Lab Med; 2009 Jul; 133(7):1116-20. PubMed ID: 19642738
[TBL] [Abstract][Full Text] [Related]
16. Hormones, receptors, and growth in hyperplastic enlarged lobular units: early potential precursors of breast cancer.
Lee S; Mohsin SK; Mao S; Hilsenbeck SG; Medina D; Allred DC
Breast Cancer Res; 2006; 8(1):R6. PubMed ID: 16417654
[TBL] [Abstract][Full Text] [Related]
17. Changes in subcellular localisation of MI-ER1 alpha, a novel oestrogen receptor-alpha interacting protein, is associated with breast cancer progression.
McCarthy PL; Mercer FC; Savicky MW; Carter BA; Paterno GD; Gillespie LL
Br J Cancer; 2008 Aug; 99(4):639-46. PubMed ID: 18665173
[TBL] [Abstract][Full Text] [Related]
18. [Immunohistochemical investigation of steroid hormones (ER, PR) in breast cancer].
Mchedlishvili MIu; Gabunia UA; Makharoblidze ER; Burnadze KT; Piradashvili DZ
Georgian Med News; 2005 Feb; (119):65-7. PubMed ID: 15834186
[TBL] [Abstract][Full Text] [Related]
19. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
de Candia P; Akram M; Benezra R; Brogi E
Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
[TBL] [Abstract][Full Text] [Related]
20. Oestrogen receptor-alpha and -beta expression in breast implant capsules: experimental findings and clinical correlates.
Persichetti P; Segreto F; Carotti S; Marangi GF; Tosi D; Morini S
J Plast Reconstr Aesthet Surg; 2014 Mar; 67(3):308-15. PubMed ID: 24389289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
